Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy

Diabetes and Metabolism

Volumn 23, Issue 1, 1997, Pages 30-42

  Ruggiero, D ^b   Lecomte, M ^b   Michoud, E ^b   Lagarde, M ^b   Wiernsperger, N ^a  

^a INSERM   (France)

^b NONE

Author keywords

cell interactions; diabetic retinopathy; glycation; oxidative stress; retinal microvessels

Indexed keywords

ANIMAL CELL; CELL INTERACTION; CONTROLLED STUDY; COW; DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMAN; NONHUMAN; OXIDATIVE STRESS; REVIEW;

ANIMALS; BASEMENT MEMBRANE; BLOOD CELLS; CELL COMMUNICATION; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; REGIONAL BLOOD FLOW; RETINAL VESSELS;

EID: 0031053701     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (157)

1. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol, 1994, 112, 1217-1228.
2. Frank RN. Diabetic retinopathy. Progress in Retinal and Eve Research, 1995, 14, 361-392.
3. Cunha-Vaz JG. Perspectives in the treatment of diabetic retinopathy. Diabetes & Metabolism, 1992, 8, 105-116.
4. Gerritsen ME. Functional heterogeneity of vascular endothelial cells. Biochem Pharmncol, 1987, 36, 2701-2711.
5. Rymaszewski Z, Szymanski PT, Abplanalp WA, Myatt L, Di Salvo J, Cohen RM. Human retinal vascular cells differ from umbilical cells in synthetic functions and their response to glucose. Proc Soc Exp Biol Med, 1992, 199, 183-191.
6. Dodge AB. Cell-cell interactions in diabetic angiopathy. Diabetes Care, 1992, 15, 168-1180.
7. Yamagishi SI, Kobayashi KI, Yamamoto H. Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochem, Biophys Res Comm, 1993, 190, 418-425.
8. Murata T, Ishibashi T, Inomata H, Sueshi K. Media conditioned by coculture of pericytes and endothelial cells under a hypoxic state stimulate in vitro angiogenesis. Ophthalmic Res 1994, 26, 23-31.
9. Bressler J, Goldstein GW, Effect of elevated ambient glucose upon polyphosphoinositide turnover in bovine retinal endothelial cells and rat astrocytes. Exp Eye Res, 1992, 54, 871-877.
10. Hata Y, Nakagawa K, Ishibashi T, Inomata H, Ueno H, Sueishi K. Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch, 1995, 426, 479-486.
11. Wong HC, Boulton M, McLeod D, Bayly M, Clark P, Marshall J. Retinal pigment epithelial cells in culture produce retinal vascular mitogens. Arch Ophthalmol, 1988, 106, 1439-1443.
12. Karasawa Y, Okisaka S. Retinal pigment epithelial cells in culture secrete angiogenic inhibitors : in vitro study. Jpn J Ophthalmol, 1990, 34, 479-493.
13. Dejana E. Endothelial cell adhesive receptors. J Cardiovascular Pharmacol 1993, 21 (suppl. 1), 18-21.
14. Falck A, Laatikainen L. Retinal vasodilation and hyperglycaemia in diabetic children and adolescents. Acta Ophthalmol Scand, 1995, 73, 119-124.
15. Skovborg F, Nielsen AV, Lauritzen E, Hartkopp O. Diameters of the retinal vessels in diabetic and normal subjects. Diabetes, 1969, 18, 292-298.
16. Wiernsperger N. Vascular defects in the aetiology of peripheral insulin resistance in Diabetes. A critical review of hypotheses and facts. Diabetes/Metabolism Reviews, 1994, 10, 287-307.
17. Barnes AJ, Kohner EM, Johnston DG, Alberti KGMM. Severe retinopathy and mild carbohydrate intolerance : possible role of insulin deficiency and elevated circulating growth hormone. The Lancet, 1995, 1465-1468.
18. Agren A, Rehn G, Naeser P. Morphology and enzyme activities of the retinal capillaries in streptozotocin-diabetic mice. Acta Ophthalmologica, 1979, 57, 1065-1069.
19. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell SE. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci, 1994, 35, 981-990.
20. Grant MB, Mames RN, Fitzgerald C, et al. Insulin-like growth factor I as an angiogenic agent : in vivo and in vitro studies. Ann NY Acad Sci, 1993, 692, 230-242.
21. Henricsson M, Janzon L, Groop L. Progression of retinopathy after change of treatment from oral antihyperglycemic agent to insulin in patients with NIDDM. Diabetes Care, 1995, 18, 1571-1576.
22. The Diabetes Control Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
23. Boz M, Scheen AJ, Gerard PL Castillo MJ, Lefebvre PJ. Retinopathy but not neuropathy is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabete & Metabolisme, 1995, 21, 353-359.
24. Klein R, Klein BEK, Moss SE. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes, 1995, 44, 796-801.
25. McDonald D, Bailie J, Archer D, Chakravarthy U. Molecular characterization of endothelin receptors and the effect of insulin on their expression in retinal microvascular pericytes. J Cardiovasc Pharmacol, 1995, 26 (Suppl. 3), 287-289.
26. Donati G, Pournaras CJ, Munoz JL, Poitry S, Poitry-Yamate CL, Tsacopoulos M. Nitric oxide controls arteriolar tone in the retina of the miniature pig. Invest Ophthalmol Vis Sci, 1995, 36, 2228-2237.
27. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol, 1995, 113, 1538-1544.
28. Sussman I, Carson MP, Schultz V, et al. Chronic exposure to high glucose decreases myo-inositol in cultured cerebral microvascular pericytes but not in endothelium. Diabetologia, 1988, 31, 771-775.
29. Mandarino LJ, Finlayson J, Hassel JR. High glucose downregulates glucose transport activity in retinal capillary pericytes but not endothelial cells. Invest. Ophthalmol Vis Sci, 1994, 35, 964-972.
30. Feke GT, Buzney SM, Ogasawara H et al. Retinal circulatory abnormalities in type I diabetes. Invest, Ophthalmol Vis Sci 1994, 35, 2968-2975.
31. Yoshida A, Feke GT, Morales-Stoppello J, Collas GD, Goger DG, McMeel JW. Retinal blood flow alterations during progression of diabetic retinopathy. Arch Ophthalmol, 1983, 101, 225-227.
32. Ishibashi T, Tanaka K, Taniguchi Y. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes, 1981, 30, 601-606.
33. Schröder S, Palinski W, Schmid-Schönbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol, 1991, 139, 81-100.
34. Kohner EM. The problems of retinal blood flow in diabetes. Diabetes, 1976, 25 (Suppl. 2), 839-844.
35. Bursell SE, Clermont AC, Shiba T, King GL. Evaluating retinal circulation using video fluorescein angiography in control and diabetic rats. Current Eye Research, 1992, 11, 287-295.
36. Mendivil A, Cuartero V, Paz Mendivil MP. Ocular blood flow velocities in patients with proliferative diabetic retinopathy and healthy volunteers : a prospective study. Br J Ophthalmol, 1995, 79, 413-416.
37. Tooke JE. Microvascular function in human diabetes : a physiological perspective. Diabetes, 1995, 44, 721-726.
38. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Koefoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia, 1989, 32, 219-226.
39. Monnier VM, Sell DR, Nagaraj RH et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging and uremia. Diabetes, 1992, 41 (Suppl. 2), 36-41.
40. Lundquist O, Osterlin S. Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefe's Arch Clin Exp Ophthalmol, 1994, 232, 71-74.
41. Yue DK, McLennan SV, Turtle JR Pathogenesis of diabetic microangiopathy : the roles of endothelial cell and basement membrane abnormalities. Diab Med, 1992, 9, 218-220.
42. King GL, Berman AB, Bonner-Weir S, Carson MP. Regulation of vascular permeability in cell culture. Diabetes, 1987, 36, 1460-1467.
43. Kalfa TA, Gerritsen ME, Carlson EC, Binstock AJ, Tsilibary EC. Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci, 1995, 36, 2358-2367.
44. Burns MS, Panattoni CM, Anderson K, Iwahashi C. Do glial cells induce blood-retinal barrier properties in retinal vascular endothelial cells ? Invest Ophthalmol Vis Sci, 1994, 35, 1719.
45. Belloni PN, Tressler R.J. Microvascular endothelial cell heterogeneity : interactions with leukocytes and tumor cells. Cancer Met Rev, 1989/1990, 8, 353-389.
46. Suganuma T, Ohta T, Tsuyama S, Kamada T, Otsuji S, Murata F. Qualitative and quantitative analysis 'of erythrocyte surface membrane sialyl residues using affinity cytochemistry with special reference to diabetic patients. Virchows Arch [B], 1985, 49, 1-11.
47. Raz I, Havivi Y, Yarom R. Reduced negative surface charge on arterial endothelium of diabetic rats. Diabetologia, 1988, 31, 618-620.
48. Vestweber D. Selectins : cell surface lectins which mediate the binding of leukocytes to endothelial cells. Semin Cell Biol, 1992, 3, 211-220.
49. Påhlsson P, Strindhall J, Srinivas U, Lundblad A. Role of N-linked glycosylation in expression of E-selectin on human endothelial cells. Eur J Immunol, 1995, 25, 2452-2459.
50. Bevilacqua MOP, Nelson, RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med, 1994, 45, 361-378.
51. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature Lond, 1981, 289, 647-650.
52. Kubes P, Suzuki M, Granger DN. Nitric oxide : an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA, 1991, 88, 4651-4655.
53. Prescott SM, McIntyre TM, Zimmerman GA. The role of platelet-activating factor in endothelial cells. Thromb Haemostasis, 1990, 64, 99-103.
54. Baumgartner-Parzer SM, Wagner L, Pettermann M, Gessl A, Waldbäusl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia, 1995, 38, 1367-1370.
55. Redding Bullard S, Hatchell DL, Cohen HJ, Murali Krishna Rao K. Increased adhesion of neutrophils to retinal vascular endothelial cells exposed to hyperosmolarity. Exp Eye Res, 1994, 58, 641-647.
56. Kim JA, Berliner JA, Natarajan RD, Nadker JL. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes, 1994, 43, 1103-1107.
57. Kohner, EM, Porta, M, Hyer, SL. The pathogenesis of diabetic retinopathy and cataract. In : Chronic Complications of Diabetes, Pickup J.C. & Williams G. (ed), Blackwell Scientific Publication, Oxford, 1994, 52-62.
58. Pietersma A, De Jong N, Koster JF, Sluiter W. Effect of hypoxia on adherence of granulocytes to endothelial cells in vitro. Am J Physiol, 1994, 267, 874-879.
59. Nerem RM, Harrison DG, Taylor WR, Alexner RW. Hemodynamics and vascular endothelial biology. J Cardiovascular Pharmacol, 1993, 21 (Suppl. 1), 6-10.
60. Tsao PS, Lewis NP, Alpert S, Cooke JP. Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide. Circulation, 1995, 92, 3513-3519.
61. Winocour PD Platelet abnormalities in Diabetes Mellitus. Diabetes 1992, 41 (Suppl. 2), 26-31.
62. Lupu C, Rizescu M, Calb M. Altered distribution of some surface glycosaminoglycans and glyconjugates on human blood platelets in diabetes mellitus. Platelets, 1994, 5, 201-208.
63. Wu YP, Sixma JJ, De Groot PG. Cultured endothelial cells regulate platelet adhesion to their extracellular matrix by regulating its von Willebrand factor content. Thromb. Haemost, 1995, 73, 713- 718.
64. La Selva M, Beltramo E, Passera P, Porta M, Molinatti GM. The role of endothelium in the pathogenesis of diabetic microangiopathy. Acta Diabetol, 1993, 30, 190-200.
65. Sims DE. Recent advances in pericyte biology. Implications for health and disease. Can J Cardiol, 1991, 7, 431-443.
66. Sharp P.S. Growth factors in the pathogenesis of diabetic retinopathy. Diabetes Reviews, 1995, 3, 164-176.
67. Sharma NK, Gardiner TA, Archer DB. A morphologic, autoradiographic study of cell death, regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol, 1985. 100, 51-60.
68. Orlidge A, D'Amore PA. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol, 1987, 105, 1455-1462.
69. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore P. An activated form of transforming growth factor is. produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA, 1989, 86, 4544-4548.
70. Verbeek MM, Westphal JR, Ruiter DJ, De Waal RM. T lymphocyte adhesion to humain brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions. J Immunol 1995, 154, 5876-5884.
71. Sawa H, Kamada K, Sato H et al. C-CAM expression in the developing rat central nervous system. Dev Brain Res 1994, 78, 35-43.
72. Swinscoe JC, Carlson EC. Capillary endothelial cells secrete a heparin-binding mitogen for pericytes. J Cell Sci, 103, 453-461.
73. Nomura M, Yamagishi S, Harada S et al. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem, 1995, 270, 28316-28324.
74. Zimmerman LH, Levine RA, Farber HW. Hypoxia induces a specific set of stress proteins in cultured endothelial cells. J Clin Invest, 1991, 87, 908-914.
75. Marino LJ, Sundarraj N, Finlayson J, Hassel JR. Regulation of fibronectin and laminin synthesis by retinal capillary endothelial cells and pericytes in vitro. Exp Eye Res, 1993, 57, 609-621.
76. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct alpha v integrins. Science, 1995, 270, 1500-1502.
77. Schmidt AM, Hon O, Brett J, Yan SD, Wautier JL, Stem D. Cellular receptors for advanced glycation end products Arterioscler. Thromb, 1994, 14, 1521-1528.
78. Yamagishi S, Hsu CC, Taniguchi M et al. Receptor-mediated toxicity to pericytes of advanced glycosylation end products : a possible mechanism of pericyte loss in diabetic microangiopathy. Biochem Biophys Res Comm, 1995, 213, 681-687.
79. Fisher EJ, McLennan SV, Yue DK, Turtle JR. Cell-associated proteoglycans of retinal pericytes and endothelial cells : modulation by glucose and ascorbic acid. Microvasc. Res, 1994, 48, 179-189.
80. Greenwood J. Astrocytes, cerebral endothelium and cell culture : the pursuit of an in vitro blood-brain barrier. Ann N Y Acad Sci 1991, 633, 426-430.
81. Kohner EM, Dollery CT, Bulpitt CJ. Cotton-wool spots in diabetic retinopathy. Diabetes, 1969, 18, 691-704.
82. Wallow IHL, Geldner PS. Endothelium fenestrae in proliferative diabetic retinopathy. Invest Ophthal Vis Sci, 1980, 19, 1176-1183.
83. Michaelson IC. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK, 1948, 68, 137-180.
84. Baird A, Esch F, Gospodarowicz D, Guillemin R. Retina and eye-derived endothelial cell growth factors : partial molecular characterization and identity with acidic and basic fibrobalast growth factors. Biochemistry, 1985, 24, 7855-7859.
85. Meyer-Schwickerath R, Pfeiffer A, Blum WF et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin growth factor proteins 2 and 3, increase in neovasclar eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest, 1994, 92, 2620-2625.
86. Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patient with diabetic retinopathy and other retinal diseases. N Engl J Med, 1994, 331, 1480-1487.
87. Stone J, Itin A, Alon T et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelium growth factor (VEGF) expression by neuroglia. J Neurosci, 1995, 15, 4738-4747.
88. Leung DW, Cachianes, G, Kuang, WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 1989, 246, 1306-1309.
89. Ferrara N, Houck KA, Jakeman LB, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev, 1992, 13, 18-32.
90. Koch AE, Harlow LA, Haines GK et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol, 1994, 152, 4149-4156.
91. Mandriota SJ, Seghezzi G, Vassalli JD et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem, 1995, 270, 9709-9716.
92. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol, 1992, 153, 557-562.
93. Watanabe T, Raff MC. Retinal astrocytes from the optic nerve. Nature, 1988, 332, 834-837.
94. Schnitzer J. Retinal astrocytes : their restriction to vascularized parts of the mammalian retina. Neurosci Letts, 1987, 78, 29-34.
95. Laterra J, Guerin C, Goldstein GW. Astrocytes induce neuronal microvascular endothelial cells to form capillary-like structures in vitro. J Cell Physiol, 1990, 144, 204-215.
96. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature, 1987, 325, 253-257.
97. Plateel M, Dehouck M-P, Torpier G, Cecchelli R, Teissier E. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J Neurochem, 1995, 65, 2138-2145.
98. Gardner TW. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy. Trans Am Ophthalmol Soc, 1995, 93, 583-621.
99. Tout S, Chan-Ling T, Hollander H, Stone J. The role of Müller cells in the formation of the blood-retinal barrier. Neuroscience, 1993, 55, 291-301.
100. Watanabe T, Mio Y, Hoshino FB, Nagamatzu S, Hirosawa K, Nakahara K. GLUT2 expression in the rat retina : localization in the apical ends of Müller cells. Brain Res, 1994, 655, 128-134.
101. Hicks D, Courtois Y. The growth and behavior of rat retinal Müller cells in vitro : 1. An improved method for isolation and culture. Exp Eye Res, 1990, 51, 119-129.
102. Mullarkey CJ, Brownlee M. Biochemical basis of microvascular disease In : Chronic Complications of Diabetes, Pickup JC & Williams G (ed), 1994, 20-33, Blackwell Scientific Publications, Oxford.
103. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes, 1991, 40, 405-412.
104. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Biochem J, 1988, 256, 205-212.
105. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med, 1994, 16, 383-391.
106. Aiello LP, Robinson GS, Lin YW, Nishio Y, King GL. Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci USA, 1994, 91, 6231-6235.
107. Garrett JR, Winston DC, Proctor GB, Schulte BA, Andersen LC. Changes in the lectin-binding of capillaries in rat salivary glands after streptozotocin-induced diabetes Archs. Oral Biol, 1992, 37, 759-761.
108. Chandramouli V, Williams S, Marshall JS, Carter JR. Cell surface changes in diabetic rats. Studies of lectin binding to liver cell plasma membranes. Biochim. Biophys Acta, 1977, 465, 19-33.
109. Varki A. Biological roles of oligosaccharides : all of the theories are correct. Glycobiology, 1993, 3, 97-130.
110. Griffiths HR, Lunec J. The effects of oxygen free radicals on the carbohydrate moiety of IgG. FEBS Lett, 1989, 245, 95-99.
111. Porta M, Molinatti PA, Dosso AA, Williams FMK, Brooks RA, Kohner EM Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations. Diabet Metab, 1994, 20, 25-30.
112. Chibber R, Molinatti PA, Wong JSK, Mirlees D, Kohner EM. The effect of aminoguanidine andtolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes, 1994, 43, 758-63.
113. Cohen MP, Hud E, Wu VY, Ziyadeh FN. Glycaled albumin modified by Amadori adducts modulates aortic endothelial cell biology. Mol Cell Biochem, 1995, 143, 73-9.
114. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation : biochemical, biologic and clinical implications for diabetes and aging. Lab Invest, 1994, 70, 138-51.
115. Gugliucci A, Bendayan M. Histones from diabetic rats contain increased levels of advanced glycation end products. Biochem. Biophys. Res Comm, 1995, 212, 56-62.
116. Giardino I, Edelstein D, Brownlee M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest, 1994, 94, 110-117.
117. Shires TK, Faeth BS, Pulido JS. Nonenzymatic glycosylation of vitreous proteins in vitro and in the streptozotocin-treated diabetic rat. Retina, 1990, 10, 153-158.
118. Schmidt AM, Hori O, Chen JX et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and mice. J Clin Invest, 1995, 96, 1395-1403.
119. Wautier JL, Zoukourian C, Chappey O et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. J Clin Invest, 1996, 97, 238-243.
120. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA, 1991, 88, 11555-11558.
121. Hammes HP, Strödter D, Weiss A, Bretzel RG, Federlin K, Brownlee M. Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model. Diabetologia, 1995, 38, 656-660.
122. Hammes HP, Syed Ali S, Uhlmann M et al. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats. Diabetologia, 1995, 38, 269-273.
123. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease : An overview. Methods Enzymol, 1990, 186, 1-85.
124. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH. Increased diene conjugates in diabetic subjects with microangiopathy. Diabetic Med, 1987, 4, 452-456.
125. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 1986, 320, 454-456.
126. Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals, endothelium and responsiveness of vascular smooth muscle. Am J Physiol. 1986, 250, H815-H821.
127. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Lefebvre PJ. Metabolic control may influence the increased superoxide generation in diabetic serum. Diab Med, 1991, 8, 540-542.
128. Lyons TJ. Glycation and oxidation : A role in the pathogenesis of atherosclerosis. Am J Cardiol, 1993, 71, 26B-31B.
129. Velazquez E, Winocour PH, Kesteven P, Alberli KGMM, Laker MF. Relation of lipid peroxides to macrovascular disease in Type 2 diabetes. Diab Med, 1991, 8, 752-758.
130. Niskanen LK, Salonen JT, Nyyssönen K, Uusitupa MU. Plasma lipid peroxidation and hyperglycaemia : a connection through hyperinsulinaemia ? Diab Med, 1995, 12, 802-808.
131. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes, 1995, 44, 1054-1058.
132. 2α levels are elevated in individuals with non-insulin-dependent diabetes mellitus. FEBS Lett., 1995, 368, 225-229.
133. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism. Proc Natl Acad Sci USA, 1990, 87, 9383-9387.
134. Fukunaga M, Makita N, Roberts LJ II, Morrow JD, Takahashi K, Badr KF. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol, 1993, 264, C1619-C1624
135. Tang DG, Timar J, Grossi IM et al. The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp Cell Res, 1993, 207, 361-375.
136. Lanadio-Schwartzman M, Lavrosky Y, Stoltz RA et al. Activation of nuclear factor KB B and oncogene expression by 12(R)-Hydroxyeicosatrienoic acid, an angiogenic factor in microvessel endothelial cells. J Biol Chem, 1994, 269, 24321-24327.
137. Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M. Docosahexaenoic acid is a major polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem, 1996, 66, in press.
138. Harrison HE, Reece AH, Johnson M. Decreased vascular prostacyclin in experimental diabetes. Life Sci, 1978, 23, 354-356.
139. Pieper GM, Gross G. Oxygen-derived free-radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol, 1988, 255, H825-H833.
140. Pieper GM, Jordan M, Dondlinger LA, Adams MB, Roza AM. Peroxidative stress in diabetic blood vessels : Reversal by pancreatic islet transplantation. Diabetes, 1995, 44, 884-889.
141. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med, 1995, 1, 27-31.
142. Lutty GA, Mello RJ, Chandler C, Fait C, Bennett A, Patz A. Regulation of cell growth by vitreous humour. J Cell Sci, 1985, 76, 53-65.
143. Kourembanas S, Hannana RL, Faller DV. Oxygen tension regulates the expression of platelet-derived growth factor B-chain in human endothelial cells. J Clin Invest, 1990, 86, 670-674.
144. Sakuda H, Nakashima Y, Kuriyama S, Sueishi K. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environment stimulates in vitro angiogenesis. A relationship to transforming growth factor-B1. Am J Pathol, 1992, 141, 1507-1516.
145. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 1992, 359, 843-845.
146. Brogi E, Schatteman G, Wu T et al. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest, 1996, 97, 469-476.
147. Goldberg MA, Schneider TJ. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelium growth factor and erythropoietin. J Biol Chem, 1994, 269, 4355- 4359.
148. Bensaid M, Malecaze, F, Prats H, Bayard F, Tauber JP. Autocrine regulation of bovine retinal capillary endothelial cell (BREC) proliferation by BREC-derived basic fibroblast growth factor. Exp Eye Res, 1989, 48, 801-803.
149. Reygrobellet D, Baudouin C, Negre F, Caruelle JP, Gastaud P, Lapalus P, Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and vitreoretinopathy. Ophthalmic Res, 1991, 23, 154-161.
150. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patient with proliferative diabetic retinopathy. Arch Ophthalmol, 1990, 108, 869-872.
151. Hanneken A, de Juan E Jr, Lutty GA, Fox GM, Schiffer S, Hjelmeland LM. Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol, 1991, 109, 1005-1011.
152. Ku P-T, D'Amore PA. Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells. J Cell Biol, 1995, 58, 328-343.
153. Soyombo AA, DiCorleto PE. Stable expression of human platelet-derived growth factor B chain by bovine aortic endothelial cells. Matrix association and selective proteolytic cleavage by thrombin. J Biol Chem, 1994, 269, 17734-17740.
154. Taipale J, Miyazono K, Heldin CH, Keski Oja J. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol, 1994, 124, 171-181.
155. McCaffrey TA, Falcone DJ, Brayton CF, Agarwal LA, Welt FGP, Weksler BB. Transforming growth factor-β is potentiated by heparin via dissection of the transforming growth factor-β/α2-macroglobulin inactive complex. J Cell Biol, 1989, 109, 441-448.
156. Lyons RM, Gentry LE, Purchio AE, Moses HL. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol, 1990, 110, 1361-1367.
157. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β1 in a chemically-defined system. J Biol Chem, 1994, 269, 26775-26782.